FOXO4-DRI (FOX04-DRI) — Senolytic Research Peptide
✅ Synthetic ~28-aa D-amino-acid retro-inverso senolytic peptide ✅ Disrupts FOXO4-p53 binding → p53 mitochondrial translocation → senescent-cell apoptosis ✅ Landmark Baar/de Keizer/Demaria 2017 Cell-paper compound ✅ Selective senolysis: spares non-senescent cells; protease-resistant via D-AA design ✅ MW ~3,000 Da; canonical peptide senolytic research tool FOXO4-DRI (also FOX04-DRI) contains synthetic retro-inverso senolytic research peptide.
Specifications
- Strength
- 10 mg
- Quantity
- 10 Vials, 20 Vials, 30 Vials
AI Readiness
Good foundation, but some important product data is still missing.
74%